Search research articles
Contact Us
Filters
Showing results (571-580 of 616) with videos related to
Page
of 62
Sort By:
European Heart Journal
|
March 30, 2020
Effects of dapagliflozin in DAPA-HF according to background heart failure therapy
Kieran F Docherty, Pardeep S Jhund, Silvio E Inzucchi, et al.
European Heart Journal. Cardiovascular Pharmacotherapy
|
February 16, 2026
A Bayesian analysis of finerenone in heart failure with mildly reduced and preserved ejection fraction: a pre-specified analysis of FINEARTS-HF
Alasdair D Henderson, Kieran F Docherty, Atefeh Talebi, et al.
Journal of the American College of Cardiology
|
August 30, 2022
Atrial Fibrillation and Dapagliflozin Efficacy in Patients With Preserved or Mildly Reduced Ejection Fraction
Jawad H Butt, Toru Kondo, Pardeep S Jhund, et al.
European Journal of Heart Failure
|
November 4, 2025
Finerenone in patients with severe heart failure: The FINEARTS-HF trial
Riccardo M Inciardi, Henri Lu, Brian L Claggett, et al.
Circulation. Heart Failure
|
January 29, 2026
Finerenone, Liver Biomarkers, and Heart Failure With Mildly Reduced/Preserved Ejection Fraction: An Analysis of FINEARTS-HF
Jawad H Butt, Alasdair D Henderson, Pardeep S Jhund, et al.
JAMA Cardiology
|
November 12, 2023
Decline in Estimated Glomerular Filtration Rate After Dapagliflozin in Heart Failure With Mildly Reduced or Preserved Ejection Fraction: A Prespecified Secondary Analysis of the DELIVER Randomized Clinical Trial
Finnian R Mc Causland, Brian L Claggett, Muthiah Vaduganathan, et al.
Journal of the American College of Cardiology
|
December 12, 2024
Finerenone, Obesity, and Heart Failure With Mildly Reduced/Preserved Ejection Fraction: Prespecified Analysis of FINEARTS-HF
Jawad H Butt, Alasdair D Henderson, Pardeep S Jhund, et al.
JAMA Network Open
|
August 27, 2021
Effect of Continuous Electrocardiogram Monitoring on Detection of Undiagnosed Atrial Fibrillation After Hospitalization for Cardiac Surgery: A Randomized Clinical Trial
Andrew C T Ha, Subodh Verma, C David Mazer, et al.
Circulation
|
October 12, 2020
Efficacy of Dapagliflozin on Renal Function and Outcomes in Patients With Heart Failure With Reduced Ejection Fraction: Results of DAPA-HF
Pardeep S Jhund, Scott D Solomon, Kieran F Docherty, et al.
Clinical Journal of the American Society of Nephrology : CJASN
|
April 28, 2022
Dapagliflozin and Kidney Outcomes in Hospitalized Patients with COVID-19 Infection: An Analysis of the DARE-19 Randomized Controlled Trial
Hiddo J L Heerspink, Remo H M Furtado, Otavio Berwanger, et al.
Page
of 62
Search research articles
Search
Showing results (571-580 of 616) with videos related to
Sort By:
Page
of 62
European Heart Journal
|
March 30, 2020
Effects of dapagliflozin in DAPA-HF according to background heart failure therapy
Kieran F Docherty, Pardeep S Jhund, Silvio E Inzucchi, et al.
European Heart Journal. Cardiovascular Pharmacotherapy
|
February 16, 2026
A Bayesian analysis of finerenone in heart failure with mildly reduced and preserved ejection fraction: a pre-specified analysis of FINEARTS-HF
Alasdair D Henderson, Kieran F Docherty, Atefeh Talebi, et al.
Journal of the American College of Cardiology
|
August 30, 2022
Atrial Fibrillation and Dapagliflozin Efficacy in Patients With Preserved or Mildly Reduced Ejection Fraction
Jawad H Butt, Toru Kondo, Pardeep S Jhund, et al.
European Journal of Heart Failure
|
November 4, 2025
Finerenone in patients with severe heart failure: The FINEARTS-HF trial
Riccardo M Inciardi, Henri Lu, Brian L Claggett, et al.
Circulation. Heart Failure
|
January 29, 2026
Finerenone, Liver Biomarkers, and Heart Failure With Mildly Reduced/Preserved Ejection Fraction: An Analysis of FINEARTS-HF
Jawad H Butt, Alasdair D Henderson, Pardeep S Jhund, et al.
JAMA Cardiology
|
November 12, 2023
Decline in Estimated Glomerular Filtration Rate After Dapagliflozin in Heart Failure With Mildly Reduced or Preserved Ejection Fraction: A Prespecified Secondary Analysis of the DELIVER Randomized Clinical Trial
Finnian R Mc Causland, Brian L Claggett, Muthiah Vaduganathan, et al.
Journal of the American College of Cardiology
|
December 12, 2024
Finerenone, Obesity, and Heart Failure With Mildly Reduced/Preserved Ejection Fraction: Prespecified Analysis of FINEARTS-HF
Jawad H Butt, Alasdair D Henderson, Pardeep S Jhund, et al.
JAMA Network Open
|
August 27, 2021
Effect of Continuous Electrocardiogram Monitoring on Detection of Undiagnosed Atrial Fibrillation After Hospitalization for Cardiac Surgery: A Randomized Clinical Trial
Andrew C T Ha, Subodh Verma, C David Mazer, et al.
Circulation
|
October 12, 2020
Efficacy of Dapagliflozin on Renal Function and Outcomes in Patients With Heart Failure With Reduced Ejection Fraction: Results of DAPA-HF
Pardeep S Jhund, Scott D Solomon, Kieran F Docherty, et al.
Clinical Journal of the American Society of Nephrology : CJASN
|
April 28, 2022
Dapagliflozin and Kidney Outcomes in Hospitalized Patients with COVID-19 Infection: An Analysis of the DARE-19 Randomized Controlled Trial
Hiddo J L Heerspink, Remo H M Furtado, Otavio Berwanger, et al.
Page
of 62